Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Bank of America Healthcare Conference Transcript

May 12, 2022 / 03:00PM GMT
Travis Lee Steed
BofA Securities, Research Division - MD

On our last day of the conference, we welcome to join Boston Scientific. Dan Brennan; and Lauren Tengler, VP of IR, welcome.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

Thanks so much for the invitation, Travis. A pleasure to be here. Thank you.

Lauren Tengler
Boston Scientific Corporation - Director of IR

Thank you.

Questions & Answers

Travis Lee Steed;Daniel J.
BofA Securities, Research Division - MD

So Dan, I just wanted to start out, first, thinking through like the Q1 performance and March recovery. Like we've been talking to a lot of companies this week, and it seems like for most of the elective names, March, strong; April, even for some companies, similar to March or better for March and that's continued into May. Seems like elective recovery's well on track. But I'd love to get your thoughts on kind of what you're seeing around your portfolio.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot